Morgan Gallazzini
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
CLUH Inhibition by Lipocalin-2 Orchestrates Mitochondrial Disruption and Contributes to Kidney Disease.
Journal: Journal of the American Society of Nephrology : JASN
Published: May 14, 2025
Clustered Mitochondrial Homolog Inhibition by Lipocalin-2 Orchestrates Mitochondrial Disruption and Contributes to Kidney Disease.
Journal: Journal of the American Society of Nephrology : JASN
Published: May 14, 2025
Lipocalin-2 induces mitochondrial dysfunction in renal tubular cells via mTOR pathway activation.
Journal: Cell reports
Published: March 07, 2023
CRISPR/Cas9-Engineered HLA-Deleted Glomerular Endothelial Cells as a Tool to Predict Pathogenic Non-HLA Antibodies in Kidney Transplant Recipients.
Journal: Journal of the American Society of Nephrology : JASN
Published: May 25, 2021
Lipocalin-2 Regulates Epidermal Growth Factor Receptor Intracellular Trafficking.
Journal: Cell reports
Published: November 14, 2018
Signaling pathways predisposing to chronic kidney disease progression.
Journal: JCI insight
Published: November 13, 2018
Endoplasmic reticulum stress and kidney dysfunction.
Journal: Biology of the cell
Published: April 09, 2018
The costimulatory receptor B7-1 is not induced in injured podocytes.
Journal: Kidney international
Published: May 18, 2016
Molecular pathways of chronic kidney disease progression.
Journal: Nephrologie & therapeutique
Published: March 15, 2016
MicroRNA-146a in Human and Experimental Ischemic AKI: CXCL8-Dependent Mechanism of Action.
Journal: Journal of the American Society of Nephrology : JASN
Published: January 13, 2016
Stat3 Controls Tubulointerstitial Communication during CKD.
Journal: Journal of the American Society of Nephrology : JASN
Published: September 14, 2015
Last Updated: 09/26/2026